The package doubles the number of banned ships in Russia’s so-called shadow fleet, the ill-maintained flock of oil and gas tankers that Moscow uses to circumvent a maximum oil price agreed on by the ...

Regeneron and Bayer's efforts to defend their lucrative eye disease therapy Eylea from competition have been boosted by FDA approval of a new high-dose formulation of the drug. The US regulator ...

While the company’s blockbuster drug — an eye medicine used to treat macular degeneration called Eylea — pulled in nearly $6bn in sales last year, growth is slowing. Its patents are set to ...

Mirikizumab, a p19-directed antibody against interleukin-23, showed efficacy in the treatment of ulcerative colitis in a phase 2 trial. We conducted two phase 3, randomized, double-blind, placebo ...

The new results in DMO – the most common cause of sight loss in people with diabetes – suggest that the differences between Beovu and Eylea could be less stark. Updated results from the second ...

Regeneron's first-quarter results miss on lower Eylea demand Regeneron's first-quarter results missed Wall Street estimates on Tuesday due to stiff competition for its blockbuster drug Eylea ...

We’re at the height of the Streaming Wars, and deciding for which platform you’re willing to pay a premium can be as challenging as figuring out your favorite ice cream on a hot summer’s day.

Sales of Regeneron’s Eylea franchise dropped 26% year-on-year, bringing in $1.04 billion in the U.S. The 23andMe acquisition could also help Regeneron bolster its gene therapy pipeline. In February, ...

Dani Wexelman, a radio host for MLB and ESPN, suggested that the Orioles should deliver an overwhelming package to land Skenes. Baltimore has an extremely young core of hitters, while lacking ...

To script setup data populated in automated/manual way. The example below is pretty tricky because simple approach INSERT INTO... EXECUTE dbo.GenerateInsert; ends up with INSERT EXEC statement cannot ...

Ashvattha Therapeutics recently announced positive interim phase 2 results for migaldendranib (MGB). 1 MGB is described as a novel subcutaneously administered nanomedicine for the treatment of retinal ...

A case analysis provides a new understanding of the ocular side effects of Blenrep, an antibody drug conjugate that is being reviewed by the FDA as a combination treatment for patients with multiple ...